Agranulocytosis after addition of risperidone to clozapine treatment.
Godleski
L S
LS
Sernyak
M J
MJ
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced*; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D011618:Psychotic Disorders / Q000188:drug therapy; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use
D003024:Clozapine; D018967:Risperidone